April 17th 2024
Topline data from the SURMOUNT-OSA studies provide insight into the effects of tirzepatide in OSA with obesity, with Lilly disclosing plans for a regulatory submission mid-year.
Pediatric Sleep-Disordered Breathing Managed in Primary Care with Corticosteroid or Saline
January 20th 2023The study evaluated how intranasal mometasone furoate affected sleep-disordered breathing symptoms and patient quality of life by comparing its efficacy to intranasal saline in the pediatric patients.